International Journal of Medical Research & Health Sciences (IJMRHS)
ISSN: 2319-5886 Indexed in: ESCI (Thomson Reuters)
Jagrit Shachi N
Department of Pharmacology, BJ Medical College, Ahmedabad, IndiaPublications
-
Research
An Evaluation of Risk Factors and Pharmacotherapy in Post SARS-CoV-2 (COVID-19) Rhino-Cerebral Mucormycosis Patients in a Tertiary Care Teaching Hospital in Ahmedabad
Author(s): Dumatar Chandresh B, Desai Chetna K and Jagrit Shachi N*
Introduction: Mucormycosis is a highly aggressive fungal infection with 0.14 cases/1000 population prevalence in India. There have been case reports of post-COVID-19 mucormycosis but the relationship is still unclear. Objectives: This study was done to identify possible risk factors and to evaluate prescribing patterns of anti-fungal agents and associated adverse drug reactions in post-COVID-19 mucormycosis patients in tertiary care hospitals in Ahmedabad. Methods: In this prospective, observational study, patients of post-COVID-19 rhino-cerebral mucormycosis were enrolled and history-based identification of possible risk factors was done over a period of 3 months. The prescribing pattern of anti-fungal agents and supportive treatment were evaluated according to WHO core prescribing indicators. Common ADRs were recognized and their causality.. Read More»
Select your language of interest to view the total content in your interested language